Financials

  • Market Capitalization 85.08 M
  • Employee 21
  • Founded 2005
  • CEO N/A
  • Website www.pdsbiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG004NCDK82
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.04
Rapporto prezzo/fatturato
-32.26

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3913
ICCC
ImmuCell Corporation - Common Stock
9.60 USD-2.04%-3.32%-2.04%+41.38%87.19 M USD
3925
NRXS
Neuraxis, Inc. Common Stock
6.78 USD-1.60%-7.25%+17.71%+24.86%85.14 M USD
3930
PMN
ProMIS Neurosciences Inc. - Common Shares
9.45 USD-1.66%-0.11%-27.59%+1868.75%84.74 M USD
3933
CLLS
Cellectis S.A. - American Depositary Shares
1.18 USD-6.35%-18.06%-49.14%-72.30%84.67 M USD

Notizie